Mukka Proteins enters ₹5 Crore loan agreement with subsidiary United Gulf Fishery Products LLC
Mukka Proteins Limited has entered into a loan agreement with its subsidiary, United Gulf Fishery Products LLC, for an amount up to ₹5 Crore. The unsecured loan carries an interest rate of 8% per annum and has a tenure of five years. The agreement was executed on April 21, 2026.
The loan amount of ₹5 Crore is relatively small compared to the overall scale of a publicly listed company. It is an inter-corporate loan to a subsidiary, which is a common practice for operational needs and does not represent a significant new business venture or a material financial event.
The announcement pertains to a standard inter-corporate loan agreement between a parent company and its subsidiary. While it facilitates business operations, it does not inherently indicate a significant positive or negative shift in the company's financial standing or immediate outlook.
Mukka Proteins Limited announced on April 21, 2026, that it has entered into a loan agreement with its subsidiary, M/s. United Gulf Fishery Products LLC. The purpose of this agreement is to provide an inter-corporate loan to meet urgent business commitments.
The loan facility is up to ₹5,00,00,000 (Rupees Five Crore Only). Mukka Proteins Limited holds a 68% stake in the borrower, M/s. United Gulf Fishery Products LLC, making it a related party transaction. The agreement specifies an interest rate of 8% per annum, and the loan has a tenure of five years from the date of disbursal. The loan is unsecured.
The loan agreement was executed on April 21, 2026. The transaction is conducted on an arm's length basis. As of the disclosure date, the amount of loan outstanding is Nil.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under related party transactions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.